Search Login Register

nuclear matrix protein 22 Summary

Description: a commercially available tumor marker for the detection of cell carcinoma of the urinary tract

Also Known As: NMP22

Networked: 195 relevant articles (25 outcomes, 42 trials/studies) for this Bio-Agent

Key Diseases for which nuclear matrix protein 22 is Relevant

  1. Urinary Bladder Neoplasms (Bladder Cancer) : 13 outcomes 27 studies in 140 results
  2. Neoplasms (Cancer) : 3 outcomes 11 studies in 76 results
  3. Transitional Cell Carcinoma : 3 outcomes 9 studies in 46 results
  4. Hematuria : 3 outcomes 9 studies in 29 results
  5. Carcinoma (Carcinomatosis) : 3 outcomes 2 studies in 24 results
Show All >>

Drugs Related to nuclear matrix protein 22

  1. nuclear matrix protein 22
  2. Antigens
  3. Telomerase (Telomerase Reverse Transcriptase)
  4. Biological Tumor Markers (Tumor Markers)
  5. Hemoglobins (Hemoglobin)
  6. formycin diphosphate (FDP)
  7. Fibronectins (Fibronectin)
  8. antigen CYFRA21.1
  9. Biological Markers (Surrogate Marker)
  10. Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)
Show All >>

Therapies Related to nuclear matrix protein 22

  1. Urinary Diversion (Ileal Conduit)
  2. Aftercare (After-Treatment)
  3. Cystectomy
  4. Stents
  5. Anesthesia

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.